Elsevier Expands ScienceDirect College Edition
Now College Students Will Have Access to Peer-Reviewed Content Going Back to 1995
Amsterdam, 26 November 2007 – Elsevier, a leading scientific and healthcare publisher announced today that their license for two- and four-year colleges, ScienceDirect College Edition, will be expanded to include content going back to 1995 at no additional cost to the customer. The expansion, which will take effect January 2008, means colleges will have access to more content of high-quality journals and reference works to enhance teaching and learning.
Before the content expansion colleges had access to 4 years of content. With the expansion, students and faculty will be able to access content from 1995 to present day which means access to almost two million full-text articles across 1,850 journals.
“We decided all customers should have access to the same content years – regardless of when they started, enabling them to access quality information covering more than a decade of science,” explains Andrea Schweikert, Director, Global Accounts. “The expansion is all about the relationship we’ve worked so hard to develop with our customers.”
“The decision to expand content back to 1995 enhances access for current colleges, makes the offer even more compelling for new colleges and demonstrates Elsevier’s commitment to meeting the needs of this specific market segment,” explains Rochelle Gore, Director of Sales, Global Accounts North America.
According to Dorit Lange, Head of Marketing Global Accounts, the response to the news that the content will be expanded has been overwhelmingly positive. “Several library directors have sent us emails applauding the decision to expand the content.”
For more information visit www.info.sciencedirect.com/colleges.
# # #
About ScienceDirect
Over a quarter of the world's full text scientific, technical and medical (STM) articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect (http://www.sciencedirect.com).
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over eight million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2,000 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and e-Books in all fields of science seamlessly interlinks with primary research referenced in journal articles.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Media Contact:
Bernadette McCauley
Elsevier
+31 20 485 3069
b.mccauley@elsevier.com
